critical care of heart transplantation. heart transplant 1960s: first heart transplants performed...
TRANSCRIPT
Critical Care of Heart Transplantation
Heart Transplant1048708 1960s
1048708 First heart transplants performed
1048708 1980s
1048708 Anti-rejection meds became available (Cyclosporine)
1048708 Today
1048708 About 80 of heart transplants are alive two years after the operation
1048708 50 percent survive 5 years
042123 2dr yekehfallah-phd of nursing -2015
Clinical Indications forHeart Transplant
1048708 Ischemic cardiomyopathy
1048708 Idiopathic cardiomyopathy
1048708 Viral cardiomyopathy
1048708 Congenital heart disease
1048708 Valvular heart disease
042123 3dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications
Absolute ContraindicationsI A Systemic illness that will limit survival despite heart
translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3
IV SLE or Sarcoid that has multisystem involvement and is still active
V Any systemic illness with a high probability of recurrence in the transplanted heart
VI B Fixed pulmonary hypertension
042123 4dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications Relative Contraindications
Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic
carotid stenosis of less severity
Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky
HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease
042123 5dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Left andor Right Heart Catherization
1048708 Echocardiogram
1048708 EKG
1048708 24 hour Holter Monitor
1048708 Carotid and peripheral doppler flow studies
1048708 Cardiopulmonary Stress Test
1048708 Metabolic exercise test that determines the
maximal oxygen consumption
042123 6dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Pulmonary
1048708 Chest radiograph
1048708 CT Chest
1048708 PFTrsquos ndash baseline screening spirometry
042123 7dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Heart Transplant1048708 1960s
1048708 First heart transplants performed
1048708 1980s
1048708 Anti-rejection meds became available (Cyclosporine)
1048708 Today
1048708 About 80 of heart transplants are alive two years after the operation
1048708 50 percent survive 5 years
042123 2dr yekehfallah-phd of nursing -2015
Clinical Indications forHeart Transplant
1048708 Ischemic cardiomyopathy
1048708 Idiopathic cardiomyopathy
1048708 Viral cardiomyopathy
1048708 Congenital heart disease
1048708 Valvular heart disease
042123 3dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications
Absolute ContraindicationsI A Systemic illness that will limit survival despite heart
translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3
IV SLE or Sarcoid that has multisystem involvement and is still active
V Any systemic illness with a high probability of recurrence in the transplanted heart
VI B Fixed pulmonary hypertension
042123 4dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications Relative Contraindications
Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic
carotid stenosis of less severity
Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky
HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease
042123 5dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Left andor Right Heart Catherization
1048708 Echocardiogram
1048708 EKG
1048708 24 hour Holter Monitor
1048708 Carotid and peripheral doppler flow studies
1048708 Cardiopulmonary Stress Test
1048708 Metabolic exercise test that determines the
maximal oxygen consumption
042123 6dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Pulmonary
1048708 Chest radiograph
1048708 CT Chest
1048708 PFTrsquos ndash baseline screening spirometry
042123 7dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Clinical Indications forHeart Transplant
1048708 Ischemic cardiomyopathy
1048708 Idiopathic cardiomyopathy
1048708 Viral cardiomyopathy
1048708 Congenital heart disease
1048708 Valvular heart disease
042123 3dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications
Absolute ContraindicationsI A Systemic illness that will limit survival despite heart
translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3
IV SLE or Sarcoid that has multisystem involvement and is still active
V Any systemic illness with a high probability of recurrence in the transplanted heart
VI B Fixed pulmonary hypertension
042123 4dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications Relative Contraindications
Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic
carotid stenosis of less severity
Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky
HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease
042123 5dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Left andor Right Heart Catherization
1048708 Echocardiogram
1048708 EKG
1048708 24 hour Holter Monitor
1048708 Carotid and peripheral doppler flow studies
1048708 Cardiopulmonary Stress Test
1048708 Metabolic exercise test that determines the
maximal oxygen consumption
042123 6dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Pulmonary
1048708 Chest radiograph
1048708 CT Chest
1048708 PFTrsquos ndash baseline screening spirometry
042123 7dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications
Absolute ContraindicationsI A Systemic illness that will limit survival despite heart
translplantII NeoplasmIII HIVAIDS CDC definition of CD4 count of lt 200 cellsmm3
IV SLE or Sarcoid that has multisystem involvement and is still active
V Any systemic illness with a high probability of recurrence in the transplanted heart
VI B Fixed pulmonary hypertension
042123 4dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications Relative Contraindications
Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic
carotid stenosis of less severity
Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky
HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease
042123 5dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Left andor Right Heart Catherization
1048708 Echocardiogram
1048708 EKG
1048708 24 hour Holter Monitor
1048708 Carotid and peripheral doppler flow studies
1048708 Cardiopulmonary Stress Test
1048708 Metabolic exercise test that determines the
maximal oxygen consumption
042123 6dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Pulmonary
1048708 Chest radiograph
1048708 CT Chest
1048708 PFTrsquos ndash baseline screening spirometry
042123 7dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Heart Transplant Contraindications Relative Contraindications
Age over 65 Peripheral vascular disease Asymptomatic carotid stenosis gt 75 or symptomatic
carotid stenosis of less severity
Uncorrected abdominal aortic aneurysm gt 4 ndash 6 cm Systemic infection making immune suppression risky
HIV HBV CMV (positive donor to negative recipient) Severe pulmonary disease
042123 5dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Left andor Right Heart Catherization
1048708 Echocardiogram
1048708 EKG
1048708 24 hour Holter Monitor
1048708 Carotid and peripheral doppler flow studies
1048708 Cardiopulmonary Stress Test
1048708 Metabolic exercise test that determines the
maximal oxygen consumption
042123 6dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Pulmonary
1048708 Chest radiograph
1048708 CT Chest
1048708 PFTrsquos ndash baseline screening spirometry
042123 7dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Left andor Right Heart Catherization
1048708 Echocardiogram
1048708 EKG
1048708 24 hour Holter Monitor
1048708 Carotid and peripheral doppler flow studies
1048708 Cardiopulmonary Stress Test
1048708 Metabolic exercise test that determines the
maximal oxygen consumption
042123 6dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Pulmonary
1048708 Chest radiograph
1048708 CT Chest
1048708 PFTrsquos ndash baseline screening spirometry
042123 7dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Pulmonary
1048708 Chest radiograph
1048708 CT Chest
1048708 PFTrsquos ndash baseline screening spirometry
042123 7dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Renal
1048708 Urinalysis
1048708 24 hour urine for creatinine clearance
1048708 Renal ultrasound
1048708 Gastrointestinal
1048708 Stool guiac
1048708 Abdominal ultrasound
1048708 CT abdominal and pelvis
1048708 Colonoscopy
042123 8dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Transplant Evaluation
1048708 Antibody screen
1048708 HLA typing
1048708 Infectious disease serologies
1048708 General laboratory studies
1048708 Bone density scan
1048708 Cancer screens ndash gender specific tests
042123 9dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Social Services Psychiatry NeuropsychiatryConsults and Evaluation
1048708 Compliance
1048708 Support
1048708 Depression
1048708 Anxiety
1048708 Substance abuse
1048708 Finances
1048708 Knowledge deficits
042123 10dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Medical Management of Patientson Waiting List
Comprehensive CHF Management
Program
042123 11dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Patient Education
1048708 Disease Process
1048708 Medication Use
1048708 Lifestyle Changes
1048708 Fluid Restriction
1048708 Sodium Restriction
1048708 Pre Transplant Immunizations
1048708 Clinic Follow up
042123 12dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Donor Selection
Donor Factors Important for Organ Recovery1048708 Age lt 45years younger donors are better1048708 Hemodynamics - CVP1048708 CPR history ndashAny down time secondary to presumed
cardiac arrest1048708 Echo LVEF LV wall thickness ValvesAnomalies1048708 EKG ndash No Q waves1048708 Effect of high dose vasopressors
1048708 Traumatic injury to the heart
042123 13dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Donor Selection1048708 Negative serologies
1048708 No active systemic infection
1048708 No extracranial malignancies
1048708 No history IV drug use
1048708
1048708 Coronary Angiography for donors over
40yrs of age
042123 14dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 15dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 dr yekehfallah-phd of nursing -2015 16
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 17dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 18dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 19dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 20dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 21dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Major Post Transplant Complications
Rejection Infection Cardiac allograft vasculopathy (CAV) Hypertension Nephrotoxicity Malignancy
042123 22dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Rejection Invasive surveillance biopsies are the best established method for following patients
Typically 13-15 biopsies are done in the first year
Each biopsy requires a minimum of 3 samples from 3 different sites to be meaningful
A new biopsy grading has been developed for widespread adoption
042123 23dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 24dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 25dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
International Society For Heart and Lung TransplantationStandardized Grading For Cardiac Biopsies
Rejection grade Description0 No evidence of rejection
1 - Mild A - Focal
Focal perivascular andor interstitial infiltrate without myocyte damage
B - Diffuse Diffuse infiltrate without myocyte damage
2 - Moderate (focal) One focus of infiltrate with myocyte damage
3 - ModerateA - Multifocal
Multifocal infiltrate with myocyte damage
MultifocalB - Diffuse
Diffuse infiltrate with myocyte damage
4 - Severe Diffuse polymorphous infiltrate with extensive myocyte damage plusmn edema plusmn hemorrhage plusmn vasculitis
26042123 dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
GRADE 1A
GRADE 2
GRADE 1B
042123 dr yekehfallah-phd of nursing -2015 27
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
GRADE 4
GRADE 3A GRADE 3B
ThresholdMandatory
ForTherapy
042123 28dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Treatment of Rejection
Rejection without hemodynamic compromise
Oral prednisone (100 mg daily for 3 days)
IV steroids
Decision dependent on grading severity and time post transplantation
Steroid resistant rejection with or without hemodynamic compromise
Cytolytic antibodies IVIG plasmapheresis photopheresis anti-B cell antibodies rapamycin methotrexate cyclophosphamide total lymphoid irradiation
042123 29dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Long Term Challenges
Renal failure and metabolic adverse effects
Cardiac allograft vasculopathy Malignancy
042123 30dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 31dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Heart Preservation Device1) Thermoelectric cooler2) Intermittent perfusion3) Preservation solution
042123 32dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 33dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Transmedics Inc
042123 34dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Heart Preservation Device2nd GenerationDevices
042123 35dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Postoperative TransplantManagement
042123 36dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Survival Following Transplant
1048708 Operative mortality rate is between 5-10
1048708 Other leading causes of mortality include1048708 Infection (15-20)
1048708 Acute RV failure
1048708 Rejection
042123 37dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Postoperative ManagementComplicated by
1048708 Denervation
1048708 Global ischemic injury associated with
perfusion injury
1048708 Myocardial dysfunction
1048708 Dysrhythmia
1048708 Hypertension
1048708 Pulmonary Hypertension
042123 38dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Infection Post Transplant
1048708 Prophylaxis
1048708 Viral - CMV
1048708 Pneumocystis carinii
1048708 Fungal
1048708 Based on recipient and donor serologies
bull Toxoplasmosis
bull TB
bull Cocci042123 39dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
TRANSPLANT REJECTION
1048708 Three types of transplant rejection
1048708 Hyperacute
1048708 Acute
1048708 Chronic
042123 40dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Signs of Rejection1048708 Edema1048708 Increased fatigue1048708 Intolerance of exercise1048708 Onset of low grade fever1048708 Increase in weight1048708 Exertional dyspnea1048708 Enlarged heart silhouette1048708 Rub (pericardial friction)1048708 EKG voltage decreased1048708 Jugular venous distention1048708 Cardiac dysrhythmias1048708 New S3 or S41048708 Onset of hypotension1048708 Echocardiogram changes1048708
042123 41dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Immunosuppression Balance
042123 42dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Recovery Phase
Hospital Discharge
042123 43dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Home Assessment
1048708 Weight
1048708 Blood pressure
1048708 Heart rate
1048708 Temperature
1048708 Blood sugar monitoring
042123 44dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Routine Testing
1048708 Lab work
1048708 Chest X-ray
1048708 EKG
1048708 Endomyocardial biopsy and or AlloMap
1048708 Echocardiogram
1048708 Bone Densitometry
042123 45dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Transplant Clinic Visits
1048708 Health Maintenance follow-up
1048708 Continuing education
1048708 Psychosocial issues
042123 46dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Cardiac Rehabilitation
1048708 Heart rate response to exercise is blunted and
delayed
1048708 Increase in heart rate is caused by circulating
catecholamines
1048708 Maximum heart rate is achieved after exercise is
completed
1048708 Deceleration of heart rate is gradual and
prolonged
042123 47dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Long Term Follow Up
Management and Complications
042123 48dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Medical Issues
1048708 Immunosuppression
1048708 Infection
1048708 Rejection
1048708 Coronary artery
vasculopathy
1048708 Hypertension
1048708 Hyperlipidemia
1048708 Diabetes
1048708 Osteoporosis
1048708 Obesity
1048708 Renal insufficiency
1048708 Gastrointestinal disorders
1048708 Reduced exercise
tolerance
1048708 Malignancy
1048708 Poor compliance
1048708 Depression
042123 49dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Quality of Life Issues
The functional effect of an illness and its
consequent therapy upon a patient as
perceived by the patient
bull Reproduction and Sexuality
bull Recurrent Disease
bull Travel
bull Adjustment
042123 50dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Mental and Emotional Health
1048708 Quality of Life
1048708 Psychiatric Disorders
1048708 Body Image
1048708 Social Adaptation
1048708 Family Dynamics
1048708 Financial Burdens
042123 51dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Return to Work vsDisability Issues
1048708 Insurance
1048708 Employment
1048708 Vocational Rehab
1048708 Disabilities
042123 52dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
Yearly Evaluation
1048708 Cardiac catherization with Intravascular Ultrasound
1048708 Echo
1048708 Dobutamine Stress Echo
1048708 Abdominal Ultrasound
1048708 Chest X-Ray
1048708 Bone Density Scan
1048708 Labs
1048708 24-hour urine for creatinine clearance
1048708 Cancer Screens
042123 53dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 54dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015
042123 55dr yekehfallah-phd of nursing -2015